Lobbying client · LD-2 disclosures
Rare Access Action Project
Virginia
67 filings from 4 registrants · 2018–2026 · latest filed Jul 18, 2026
Reported on its behalf
$1.1M
every LD-2 on file
Its own filed spend
$0
lobbying for itself
Fees to outside firms
$1.1M
across every firm on file
Spend over time
Every filing period on record, as reported. One column per filed period — a period with no column is a period with no filing, not a zero.
Basis · Amendments and terminations supersede the original report for the same registrant, client and period, so a revised quarter is counted once at its latest filed value. Registration-only filings carry no activity money and are excluded from these totals.
Who lobbies for them
Every outside firm that has filed on this client's behalf, by fees reported.
What they lobby on
Issue areas declared on the filings, ranked by how many filings name each one.
Medicare/Medicaid
MMM
62 filings
$1.1M on those filings
Medical/Disease Research/Clinical Labs
MED
45 filings
$686K on those filings
Health Issues
Who did the lobbying
Every lobbyist named on this client's filings.
- Mcclain C Haddow Upstream Consulting33 filingsthrough 2026
- Michael J Eging Commonwealth Policy Solutions31 filingsthrough 2026
- John M. Haddow Upstream Consulting8 filingsthrough 2020
- Matthew Salmon Mjs Advisors LLC4 filingsthrough 2023
- Matt Salmon Ervin Graves Strategy Group, LLCCovered position: Member of Congress (1995-2001 and 2013-2017)
The filings
The 20 most recent of 67 filings. Every figure above is built from these records.
This record groups every filed spelling of the client's name into one entity, so "MERCK & CO., INC." and "MERCK & CO INC" read as the same company. The grouping is the client's normalized name — organizations that file under genuinely different names appear separately. Handle: rare-access-action-project.